Symtuza Interactions
There are 772 drugs known to interact with Symtuza (cobicistat/darunavir/emtricitabine/tenofovir alafenamide), along with 11 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 345 are major, 404 are moderate, and 23 are minor.
- View all 772 medications that may interact with Symtuza
- View Symtuza alcohol/food interactions (2)
- View Symtuza disease interactions (11)
Most frequently checked interactions
View interaction reports for Symtuza (cobicistat / darunavir / emtricitabine / tenofovir alafenamide) and the medicines listed below.
- alprazolam
- aspirin
- atorvastatin
- Biktarvy (bictegravir / emtricitabine / tenofovir alafenamide)
- bupropion
- cyclobenzaprine
- Descovy (emtricitabine / tenofovir alafenamide)
- doxycycline
- escitalopram
- Fish Oil (omega-3 polyunsaturated fatty acids)
- gabapentin
- hydroxyzine
- ibuprofen
- lisinopril
- metformin
- metoprolol
- montelukast
- multivitamin
- omeprazole
- prednisone
- quetiapine
- rosuvastatin
- tadalafil
- tamsulosin
- testosterone
- Tivicay (dolutegravir)
- tramadol
- Truvada (emtricitabine / tenofovir disoproxil)
- Vitamin D3 (cholecalciferol)
- vitamin e
Symtuza alcohol/food interactions
There are 2 alcohol/food interactions with Symtuza (cobicistat / darunavir / emtricitabine / tenofovir alafenamide).
Symtuza disease interactions
There are 11 disease interactions with Symtuza (cobicistat / darunavir / emtricitabine / tenofovir alafenamide) which include:
- hepatotoxicity
- hepatitis B
- hepatotoxicity
- creatinine clearance
- hemodialysis
- renal dysfunction
- hemophilia
- hyperglycemia
- bone toxicity
- liver disease
- renal dysfunction
Report options
More about Symtuza (cobicistat / darunavir / emtricitabine / tenofovir alafenamide)
- Symtuza consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (9)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: antiviral combinations
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Genvoya
Genvoya (elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide) is used to treat HIV ...
Sunlenca
Sunlenca (lenacapavir) is used for the treatment of HIV-1 infection in heavily ...
Cabenuva
Cabenuva (cabotegravir and rilpivirine) injections are a long-acting HIV treatment used to keep HIV ...
Biktarvy
Biktarvy is a complete HIV-1 treatment in a once-a-day single tablet containing three antiviral ...
Descovy
Descovy is used to treat and prevent HIV infection in adults and adolescents. When used for HIV-1 ...
Dovato
Dovato is a complete HIV-1 treatment regimen in one tablet that may be used in adults and children ...
Truvada
Truvada is used to prevent HIV (HIV PrEP) or treat HIV-1 infection in combination with other HIV-1 ...
Atripla
Atripla prevents the human immunodeficiency virus (HIV) from reproducing in your body. Learn about ...
Complera
Complera (emtricitabine, rilpivirine, and tenofovir) is used to treat HIV infection. Includes ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
